Richardson A - Search Results

1

Ivermectin Augments the Anti-Cancer Activity of Pitavastatin in Ovarian Cancer Cells.

Jawad MJ, Richardson A. Jawad MJ, et al. Among authors: richardson a. Diseases. 2023 Mar 14;11(1):49. doi: 10.3390/diseases11010049. Diseases. 2023. PMID: 36975598 Free PMC article.

2

Navitoclax augments the activity of carboplatin and paclitaxel combinations in ovarian cancer cells.

Stamelos VA, Robinson E, Redman CW, Richardson A. Stamelos VA, et al. Among authors: richardson a. Gynecol Oncol. 2013 Feb;128(2):377-82. doi: 10.1016/j.ygyno.2012.11.019. Epub 2012 Nov 17. Gynecol Oncol. 2013. PMID: 23168176

3

Inhibition of the mevalonate pathway augments the activity of pitavastatin against ovarian cancer cells.

Abdullah MI, Abed MN, Richardson A. Abdullah MI, et al. Among authors: richardson a. Sci Rep. 2017 Aug 14;7(1):8090. doi: 10.1038/s41598-017-08649-9. Sci Rep. 2017. PMID: 28808351 Free PMC article.

4

ABT-737 and pictilisib synergistically enhance pitavastatin-induced apoptosis in ovarian cancer cells.

De Wolf E, De Wolf C, Richardson A. De Wolf E, et al. Among authors: richardson a. Oncol Lett. 2018 Feb;15(2):1979-1984. doi: 10.3892/ol.2017.7516. Epub 2017 Dec 5. Oncol Lett. 2018. PMID: 29434898 Free PMC article.

5

The poor design of clinical trials of statins in oncology may explain their failure - Lessons for drug repurposing.

Abdullah MI, de Wolf E, Jawad MJ, Richardson A. Abdullah MI, et al. Among authors: richardson a. Cancer Treat Rev. 2018 Sep;69:84-89. doi: 10.1016/j.ctrv.2018.06.010. Epub 2018 Jun 18. Cancer Treat Rev. 2018. PMID: 29936313 Free article. Review.

6

Screening a library of approved drugs reveals that prednisolone synergizes with pitavastatin to induce ovarian cancer cell death.

Abdullah MI, Abed MN, Khanim F, Richardson A. Abdullah MI, et al. Among authors: richardson a. Sci Rep. 2019 Jul 3;9(1):9632. doi: 10.1038/s41598-019-46102-1. Sci Rep. 2019. PMID: 31270377 Free PMC article.

7

Identification of foods that affect the anti-cancer activity of pitavastatin in cells.

Jawad MJ, Ibrahim S, Kumar M, Burgert C, Li WW, Richardson A. Jawad MJ, et al. Among authors: richardson a. Oncol Lett. 2022 Mar;23(3):73. doi: 10.3892/ol.2022.13193. Epub 2022 Jan 5. Oncol Lett. 2022. PMID: 35111242 Free PMC article.

8

Preclinical evaluation of statins as a treatment for ovarian cancer.

Robinson E, Nandi M, Wilkinson LL, Arrowsmith DM, Curtis AD, Richardson A. Robinson E, et al. Among authors: richardson a. Gynecol Oncol. 2013 May;129(2):417-24. doi: 10.1016/j.ygyno.2013.02.003. Epub 2013 Feb 8. Gynecol Oncol. 2013. PMID: 23402903

9

New strategies for the treatment of ovarian cancer.

Robinson E, Fisher N, Stamelos V, Redman C, Richardson A. Robinson E, et al. Among authors: richardson a. Biochem Soc Trans. 2014 Feb;42(1):125-9. doi: 10.1042/BST20130203. Biochem Soc Trans. 2014. PMID: 24450639 Review.

10

Antagonism of Bcl-XL is necessary for synergy between carboplatin and BH3 mimetics in ovarian cancer cells.

Abed MN, Abdullah MI, Richardson A. Abed MN, et al. Among authors: richardson a. J Ovarian Res. 2016 Apr 14;9:25. doi: 10.1186/s13048-016-0234-y. J Ovarian Res. 2016. PMID: 27080533 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,325 results

Search Page